| STOCK BASED COMPENSATION |
10.
STOCK BASED COMPENSATION
During
the three and six months ended June 30, 2026 and 2025, the Company recognized stock based compensation associated with stock options
and stock awards granted in prior periods as follows:
SCHEDULE OF RECOGNIZED STOCK BASED COMPENSATION
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three months ended
June 30, | | |
Six months ended
June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Line item on the statement of operations and comprehensive income (loss): | |
| | |
| | |
| | |
| |
| Wages, administrative salaries and benefits | |
$ | 87,443 | | |
$ | 79,740 | | |
$ | 174,886 | | |
$ | 159,480 | |
| Professional fees | |
| 22,330 | | |
| 18,180 | | |
| 44,660 | | |
| 36,360 | |
| Stock based compensation | |
$ | 109,773 | | |
$ | 97,920 | | |
$ | 219,546 | | |
$ | 195,840 | |
The
following table summarizes the Company’s stock option activities for the six months ended June 30, 2026 and the full year ended
December 31, 2025:
SCHEDULE OF STOCK OPTION ACTIVITIES
| | |
Number of
shares | | |
Exercise price
per share | | |
Weighted
average
exercise price | |
| | |
| | |
| | |
| |
| Balance, December 31, 2024 | |
| 1,850,000 | | |
$ | 2.00 – 4.05 | | |
$ | 2.68 | |
| Granted | |
| 66,000 | | |
$ | 7.00 | | |
$ | 7.00 | |
| Cancelled or expired | |
| (5,000 | ) | |
$ | 2.00 – 3.61 | | |
$ | 2.84 | |
| Exercised | |
| (212,000 | ) | |
$ | 2.00 – 3.61 | | |
$ | 2.80 | |
| Balance, December 31, 2025 | |
| 1,699,000 | | |
$ | 2.00 – 7.00 | | |
$ | 2.83 | |
| Cancelled or expired | |
| (2,000 | ) | |
$ | 3.61 | | |
$ | 3.61 | |
| Exercised | |
| (35,000 | ) | |
$ | 2.44 – 4.05 | | |
$ | 3.04 | |
| Balance, June 30, 2026 | |
| 1,662,000 | | |
$ | 2.00 – 7.00 | | |
$ | 2.82 | |
| Exercisable, June 30, 2026 | |
| 1,046,000 | | |
$ | 2.00 – 4.05 | | |
$ | 2.73 | |
During
the six months ended June 30, 2026 and 2025, the Company did not grant any stock based compensation to employees or consultants.
As
of June 30, 2026, the weighted-average remaining contractual life of outstanding and exercisable options is 2.3 years and 2.1 years,
respectively. As of June 30, 2026, there was approximately $223,618 of compensation expense related to non-vested options that is expected
to be recognized over a weighted average period of 1.0 years.
The
aggregate intrinsic value of options outstanding and exercisable at June 30, 2026 is $6,356,600 and $4,095,040, respectively. During
the six months ended June 30, 2026, the intrinsic value of stock options exercised was $117,000 (2025 - $428,925).
During
the year ended December 31, 2025, the Company granted 50,000 shares as a stock award. The total fair value of the stock award was $350,000
with 10,000 shares vested upon issuance and 10,000 shares vest on each anniversary date through 2029. The Company distributed 10,000
shares in the three and six months ended June 30, 2026 (2025 – nil). As of June 30, 2026, there was approximately $186,160 of compensation
related to the 40,000 non-vested shares of the stock award that is expected to be recognized through 2029.
|